Skip to main content

Articles

Page 70 of 85

  1. Mesenchymal stromal/stem cells derived from human umbilical cord (UC-MSCs) uniquely combine properties of embryonic and postnatal MSCs and may be the most acceptable, safe, and effective source for allogeneic ...

    Authors: Irina Arutyunyan, Timur Fatkhudinov, Evgeniya Kananykhina, Natalia Usman, Andrey Elchaninov, Andrey Makarov, Galina Bolshakova, Dmitry Goldshtein and Gennady Sukhikh
    Citation: Stem Cell Research & Therapy 2016 7:46
  2. Previous studies have reported that adult mesenchymal stem cells (MSCs) tend to gradually lose their stem cell characteristics in vitro when placed outside their niche environment. They subsequently undergo sp...

    Authors: Stuart Webb, Chase Gabrelow, James Pierce, Edwin Gibb and Jimmy Elliott
    Citation: Stem Cell Research & Therapy 2016 7:45

    The Erratum to this article has been published in Stem Cell Research & Therapy 2016 7:62

  3. Complex interactions among cells of the monocyte-macrophage-osteoclast lineage and the mesenchymal stem cell-osteoblast lineage play a major role in the pathophysiology of bone healing. Whereas the former line...

    Authors: Emmanuel Gibon, Laura Lu and Stuart B. Goodman
    Citation: Stem Cell Research & Therapy 2016 7:44
  4. Multiple sclerosis is a widespread inflammatory demyelinating disease. Several immunomodulatory therapies are available, including interferon-β, glatiramer acetate, natalizumab, fingolimod, and mitoxantrone. A...

    Authors: Beatriz Bravo, Marta I. Gallego, Ana I. Flores, Rafael Bornstein, Alba Puente-Bedia, Javier Hernández, Paz de la Torre, Elena García-Zaragoza, Raquel Perez-Tavarez, Jesús Grande, Alicia Ballester and Sara Ballester
    Citation: Stem Cell Research & Therapy 2016 7:43
  5. Diabetic retinopathy is a common complication of diabetes and the leading cause of irreversible vision loss in the Western world. The reduction in color/contrast sensitivity due to the loss of neural cells in ...

    Authors: Marcelo Ezquer, Cristhian A. Urzua, Scarleth Montecino, Karla Leal, Paulette Conget and Fernando Ezquer
    Citation: Stem Cell Research & Therapy 2016 7:42
  6. Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that selectively affects the motor neurons. The details of the mechanisms of selective motor-neuron death remain unknown and no effecti...

    Authors: Fernanda Gubert, Ana B. Decotelli, Igor Bonacossa-Pereira, Fernanda R. Figueiredo, Camila Zaverucha-do-Valle, Fernanda Tovar-Moll, Luísa Hoffmann, Turan P. Urmenyi, Marcelo F. Santiago and Rosalia Mendez-Otero
    Citation: Stem Cell Research & Therapy 2016 7:41
  7. Transcription factor-mediated reprogramming can efficiently convert differentiated cells into induced pluripotent stem cells (iPSCs). Furthermore, many cell types have been shown to be amenable to reprogrammin...

    Authors: Shuai Gao, Li Tao, Xinfeng Hou, Zijian Xu, Wenqiang Liu, Kun Zhao, Mingyue Guo, Hong Wang, Tao Cai, Jianhui Tian, Shaorong Gao and Gang Chang
    Citation: Stem Cell Research & Therapy 2016 7:40
  8. Bone marrow mesenchymal stem cells (MSCs) have shown positive therapeutic effects for meniscus regeneration and repair. Preliminary in vitro work has indicated positive results for MSC applications for meniscu...

    Authors: Mary Clare McCorry, Jennifer L. Puetzer and Lawrence J. Bonassar
    Citation: Stem Cell Research & Therapy 2016 7:39
  9. Recently, cell-based therapeutic lymphangiogenesis has emerged and provided hope for lymphatic regeneration. Previous studies have demonstrated that secretomes of mesenchymal stem cells (MSCs) facilitate the r...

    Authors: Chang Youn Lee, Jin Young Kang, Soyeon Lim, Onju Ham, Woochul Chang and Dae-Hyun Jang
    Citation: Stem Cell Research & Therapy 2016 7:38
  10. Mesenchymal stem cells (MSCs) (also known as multipotent mesenchymal stromal cells) possess the capacity for self-renewal and multi-lineage differentiation, and their ability to enhance cutaneous wound healing...

    Authors: Dylan E. Lee, Nagi Ayoub and Devendra K. Agrawal
    Citation: Stem Cell Research & Therapy 2016 7:37
  11. Stem cell therapy can be used for alleviating the neuropathic pain induced by spinal cord injuries (SCIs). However, survival and differentiation of stem cells following their transplantation vary depending on ...

    Authors: Mahmoud Yousefifard, Farinaz Nasirinezhad, Homa Shardi Manaheji, Atousa Janzadeh, Mostafa Hosseini and Mansoor Keshavarz
    Citation: Stem Cell Research & Therapy 2016 7:36
  12. Bone marrow and adipose tissues are known sources of mesenchymal stem cells (MSCs) in horses; however, synovial tissues might be a promising alternative. The aim of this study was to evaluate phenotypic charac...

    Authors: Joice Fülber, Durvanei A. Maria, Luis Cláudio Lopes Correia da Silva, Cristina O. Massoco, Fernanda Agreste and Raquel Y. Arantes Baccarin
    Citation: Stem Cell Research & Therapy 2016 7:35
  13. Mechanical loading plays an important role in the regulation of extracellular matrix (ECM) homeostasis as well as pathogenesis of intervertebral disc (IVD) degeneration. The human annulus fibrosus (hAF) in the...

    Authors: Po-Hsin Chou, Shih-Tien Wang, Meng-Hua Yen, Chien-Lin Liu, Ming-Chau Chang and Oscar Kuang-Sheng Lee
    Citation: Stem Cell Research & Therapy 2016 7:34
  14. Periodontitis, which progressively destroys tooth-supporting structures, is one of the most widespread infectious diseases and the leading cause of tooth loss in adults. Evidence from preclinical trials and sm...

    Authors: Fa-Ming Chen, Li-Na Gao, Bei-Min Tian, Xi-Yu Zhang, Yong-Jie Zhang, Guang-Ying Dong, Hong Lu, Qing Chu, Jie Xu, Yang Yu, Rui-Xin Wu, Yuan Yin, Songtao Shi and Yan Jin
    Citation: Stem Cell Research & Therapy 2016 7:33

    The Correction to this article has been published in Stem Cell Research & Therapy 2018 9:260

  15. Pluripotent stem cells, such as embryonic stem cells or induced pluripotent stem cells, have a great potential for regenerative medicine. Induced pluripotent stem cells, in particular, are suitable for replace...

    Authors: Toru Matsu-ura, Hiroshi Sasaki, Motoi Okada, Katsuhiko Mikoshiba and Muhammad Ashraf
    Citation: Stem Cell Research & Therapy 2016 7:30
  16. Human mesenchymal stromal cells (MSCs) can be isolated from different sources including bone marrow and term placenta. These two populations display distinct patterns of proliferation and differentiation in vi...

    Authors: Jan K. Maerz, Lorenzo P. Roncoroni, David Goldeck, Tanja Abruzzese, Hubert Kalbacher, Bernd Rolauffs, Peter DeZwart, Kay Nieselt, Melanie L. Hart, Gerd Klein and Wilhelm K. Aicher
    Citation: Stem Cell Research & Therapy 2016 7:29
  17. The use of large amounts of human multipotent mesenchymal stroma/stem cells (MSC) for cell therapies represents a desirable property in tissue engineering and banking in the field of regenerative medicine.

    Authors: Yuanyuan Yang, Catharina Melzer, Vesna Bucan, Juliane von der Ohe, Anna Otte and Ralf Hass
    Citation: Stem Cell Research & Therapy 2016 7:28
  18. Mesenchymal stem/progenitor cells (MSC) have shown beneficial effects in many models of disease in part by modulating excessive inflammatory and immune responses. Frequently the beneficial effects of MSC persi...

    Authors: Nikolay Bazhanov, Joni H. Ylostalo, Thomas J. Bartosh, April Tiblow, Arezoo Mohammadipoor, Andrea Foskett and Darwin J. Prockop
    Citation: Stem Cell Research & Therapy 2016 7:27
  19. Cystic fibrosis is one of the most frequent inherited rare diseases, caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Apart from symptomatic treatments, therapeutic protocol...

    Authors: María Vicenta Camarasa and Víctor Miguel Gálvez
    Citation: Stem Cell Research & Therapy 2016 7:26

    The Retraction Note to this article has been published in Stem Cell Research & Therapy 2017 8:123

  20. The soluble factors secreted by mesenchymal stem cells are thought to either support or inhibit tumor growth. Herein, we investigated whether the human lung-derived mesenchymal stem cell-conditioned medium (hl...

    Authors: Lourdes Cortes-Dericks, Laurene Froment, Gregor Kocher and Ralph A. Schmid
    Citation: Stem Cell Research & Therapy 2016 7:25
  21. Kidney transplantation is the best treatment for end-stage renal disease, but its implementation is limited by organ shortage and immune rejection. Side effects of current immunosuppressive drugs, such as neph...

    Authors: Cheng Chen and Jianquan Hou
    Citation: Stem Cell Research & Therapy 2016 7:16
  22. Diabetic nephropathy is one of the most serious complications in patients with diabetes. At present, there are no satisfactory treatments available for diabetic nephropathy. Stem cells are currently the main c...

    Authors: Zhen-zhen Jiang, Yu-mei Liu, Xin Niu, Jian-yong Yin, Bin Hu, Shang-chun Guo, Ying Fan, Yang Wang and Nian-song Wang
    Citation: Stem Cell Research & Therapy 2016 7:24
  23. The characteristics and therapeutic potential of subtypes of mesenchymal stem cells (MSCs) are largely unknown. In this study, CD146+ and CD146– MSCs were separated from human umbilical cords, and their effects o...

    Authors: Cheng-Chi Wu, Fei-Lan Liu, Huey-Kang Sytwu, Chang-Youh Tsai and Deh-Ming Chang
    Citation: Stem Cell Research & Therapy 2016 7:23
  24. Efficacy and safety of anticancer drugs are traditionally studied using cancer cell lines and animal models. The thienodiazepine class of BET inhibitors, such as JQ1, has been extensively studied for the poten...

    Authors: Saeed Alghamdi, Irfan Khan, Naimisha Beeravolu, Christina McKee, Bryan Thibodeau, George Wilson and G. Rasul Chaudhry
    Citation: Stem Cell Research & Therapy 2016 7:22
  25. Adipose tissue-derived mesenchymal stromal cells (AT-MSCs) are frequently used to treat equine tendinopathies. Up to now, knowledge about the fate of autologous AT-MSCs after intralesional injection into equin...

    Authors: Florian Geburek, Kathrin Mundle, Sabine Conrad, Maren Hellige, Ulrich Walliser, Hans T. M. van Schie, René van Weeren, Thomas Skutella and Peter M. Stadler
    Citation: Stem Cell Research & Therapy 2016 7:21
  26. Articular cartilage has a limited potential for self-healing. Transplantation of genetically modified progenitor cells like bone marrow-derived mesenchymal stem cells (MSCs) is an attractive strategy to improv...

    Authors: Ke Tao, Janina Frisch, Ana Rey-Rico, Jagadeesh K. Venkatesan, Gertrud Schmitt, Henning Madry, Jianhao Lin and Magali Cucchiarini
    Citation: Stem Cell Research & Therapy 2016 7:20
  27. Recent advances in regenerative medicine place us in a unique position to improve the quality of engineered tissue. We use auricular cartilage as an exemplar to illustrate how the use of tissue-specific adult ...

    Authors: Zita M. Jessop, Muhammad Javed, Iris A. Otto, Emman J. Combellack, Siân Morgan, Corstiaan C. Breugem, Charles W. Archer, Ilyas M. Khan, William C. Lineaweaver, Moshe Kon, Jos Malda and Iain S. Whitaker
    Citation: Stem Cell Research & Therapy 2016 7:19
  28. Infected bone defect poses a great challenge for orthopedists because it is difficult to cure. Tissue-engineered bone based on the human mesenchymal stem cells (hMSCs), has currently taken a promising treatmen...

    Authors: Hai Wang, Xiao-Qing He, Tao Jin, Yang Li, Xin-Yu Fan, Yi Wang and Yong-Qing Xu
    Citation: Stem Cell Research & Therapy 2016 7:18
  29. Human induced pluripotent stem (hiPS) cells have the ability to undergo self-renewal and differentiation similarly to human embryonic stem (hES) cells. We have recently shown that hES cells under replication s...

    Authors: Joelle A. Desmarais, Christian Unger, Ivan Damjanov, Mark Meuth and Peter Andrews
    Citation: Stem Cell Research & Therapy 2016 7:17
  30. Bone formation and remodeling are influenced by the inflammatory state of the local microenvironment. In this regard, macrophages are postulated to play a crucial role in modulating osteogenesis. However, the ...

    Authors: Florence Loi, Luis A. Córdova, Ruth Zhang, Jukka Pajarinen, Tzu-hua Lin, Stuart B. Goodman and Zhenyu Yao
    Citation: Stem Cell Research & Therapy 2016 7:15
  31. Type 1 diabetes mellitus (T1D) is characterized by autoimmune responses resulting in destruction of insulin-producing pancreatic beta cells. Multipotent mesenchymal stromal cells (MSCs) exhibit immunomodulator...

    Authors: Juliana Navarro Ueda Yaochite, Kalil Willian Alves de Lima, Carolina Caliari-Oliveira, Patricia Vianna Bonini Palma, Carlos Eduardo Barra Couri, Belinda Pinto Simões, Dimas Tadeu Covas, Júlio César Voltarelli, Maria Carolina Oliveira, Eduardo Antônio Donadi and Kelen Cristina Ribeiro Malmegrim
    Citation: Stem Cell Research & Therapy 2016 7:14
  32. A dynamic vasculature is a prerequisite for bone formation where the interaction of bone cells and endothelial cells is essential for both the development and the healing process of bone. Enhanced understandin...

    Authors: Stefanie Inglis, David Christensen, David I. Wilson, Janos M. Kanczler and Richard O. C. Oreffo
    Citation: Stem Cell Research & Therapy 2016 7:13
  33. Neural stem cells for the treatment of spinal cord injury (SCI) are of particular interest for future therapeutic use. However, until now, stem cell therapies are often limited due to the inhibitory environmen...

    Authors: Jennifer Butenschön, Tina Zimmermann, Nikolai Schmarowski, Robert Nitsch, Barbara Fackelmeier, Kevin Friedemann, Konstantin Radyushkin, Jan Baumgart, Beat Lutz and Julia Leschik
    Citation: Stem Cell Research & Therapy 2016 7:11
  34. Amelogenin is an extracellular matrix protein well known for its role in the organization and mineralization of enamel. Clinically, it is used for periodontal regeneration and, due to its finding also in prede...

    Authors: Iris Frasheri, Christina Ern, Christian Diegritz, Reinhard Hickel, Michael Hristov and Matthias Folwaczny
    Citation: Stem Cell Research & Therapy 2016 7:10
  35. Amnion-derived stem cells have been proposed for cell replacement therapy and tissue regeneration. An easily accessible cell source, the placenta, allows us to potentially establish a bio-bank of cells for imm...

    Authors: Toshio Miki, Wisia Wong, Elton Zhou, Anthony Gonzalez, Irving Garcia and Brendan H. Grubbs
    Citation: Stem Cell Research & Therapy 2016 7:8
  36. Mesenchymal stromal cells (MSCs) are well known for their application potential in tissue engineering. We previously reported that MSCs are able to differentiate into hepatocytes in vitro. However, conventiona...

    Authors: Hao-Hsiang Wu, Jennifer H. Ho and Oscar K. Lee
    Citation: Stem Cell Research & Therapy 2016 7:6
  37. Adipose-derived mesenchymal stem cells (MSCs) have been gaining fame mainly due to their vast clinical potential, simple isolation methods and minimal donor site morbidity. Adipose-derived MSCs and microvascul...

    Authors: Alina Freiman, Yulia Shandalov, Dekel Rozenfeld, Erez Shor, Sofia Segal, Dror Ben-David, Shai Meretzki, Dana Egozi and Shulamit Levenberg
    Citation: Stem Cell Research & Therapy 2016 7:5
  38. Identification of surface markers for prospective isolation of functionally homogenous populations of human skeletal (stromal, mesenchymal) stem cells (hMSCs) is highly relevant for cell therapy protocols. Thu...

    Authors: Linda Harkness, Walid Zaher, Nicholas Ditzel, Adiba Isa and Moustapha Kassem
    Citation: Stem Cell Research & Therapy 2016 7:4
  39. Expansion protocols aim at both increasing the number of umbilical cord blood (UCB) hematopoietic stem cells and progenitor cells (HSPCs) and reducing the period of neutropenia in UCB HSPC graft. Because glyco...

    Authors: Lionel Faivre, Véronique Parietti, Fernando Siñeriz, Sandrine Chantepie, Marie Gilbert-Sirieix, Patricia Albanese, Jérôme Larghero and Valérie Vanneaux
    Citation: Stem Cell Research & Therapy 2016 7:3
  40. Many retinal degenerative diseases are caused by the loss of retinal ganglion cells (RGCs). Autosomal dominant optic atrophy is the most common hereditary optic atrophy disease and is characterized by central ...

    Authors: Jing Chen, Hamidreza Riazifar, Min-Xin Guan and Taosheng Huang
    Citation: Stem Cell Research & Therapy 2016 7:2
  41. Multiple sclerosis is a demyelinating disease mostly of autoimmune origin that affects and damages the central nervous system, leading to a disabling condition. The aim of the present study was to investigate ...

    Authors: Oriana Trubiani, Sabrina Giacoppo, Patrizia Ballerini, Francesca Diomede, Adriano Piattelli, Placido Bramanti and Emanuela Mazzon
    Citation: Stem Cell Research & Therapy 2016 7:1
  42. The use of mesenchymal stem cells (MSCs) to treat inflammatory bowel disease (IBD) is of great interest because of their immunomodulatory properties. Damage to the enteric nervous system (ENS) is implicated in...

    Authors: Rhian Stavely, Ainsley M. Robinson, Sarah Miller, Richard Boyd, Samy Sakkal and Kulmira Nurgali
    Citation: Stem Cell Research & Therapy 2015 6:263
  43. Although metformin, a first-line drug for treating diabetes, may play an important role in inhibition of epithelial ovarian cancer cell growth and cancer stem cells (CSCs), metformin at low dose showed less ef...

    Authors: Rongrong Zhang, Ping Zhang, Hong Wang, Dongming Hou, Wentao Li, Guishan Xiao and Chenwei Li
    Citation: Stem Cell Research & Therapy 2015 6:262
  44. Heterogeneity of endothelial cells (ECs) is a hallmark of the vascular system which may impact the development and management of vascular disorders. Despite the tremendous progress in differentiation of human ...

    Authors: Gopu Sriram, Jia Yong Tan, Intekhab Islam, Abdul Jalil Rufaihah and Tong Cao
    Citation: Stem Cell Research & Therapy 2015 6:261
  45. Due to their intrinsic properties, stem cells are promising tools for new developments in tissue engineering and particularly for cartilage tissue regeneration. Although mesenchymal stromal/stem cells from bon...

    Authors: Loïc Reppel, Jessica Schiavi, Naceur Charif, Léonore Leger, Hao Yu, Astrid Pinzano, Christel Henrionnet, Jean-François Stoltz, Danièle Bensoussan and Céline Huselstein
    Citation: Stem Cell Research & Therapy 2015 6:260

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    211 days submission to accept (Median)

    2023 Usage 
    3,320,811 downloads
    1,402 Altmetric mentions